Skip to content

Role of Brahmdandi ( Tricholepis glaberrima, rasanjan and mishri in menorrhagia

Pharmacotherapeutic and Pahrmacognostical Study of Brahmdandyadi yoga in the management of Raktapradara (Menorrhagia) - nill

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071469
Enrollment
100
Registered
2024-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor
Prof Chandan Singh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Well diagnosed and confirm patient of Raktapradara. 2. Patients aged between menarche and menopause of life and willing to participate in trial. 3. Excessive per vaginal bleeding for more than 2 consecutive cycles. 4. Patients suffering from PCOD.

Exclusion criteria

Exclusion criteria: 1. Patients having bleeding from carcinoma or big fibroid like conditions. 2. Patients having bleeding due to abortion. 3. Patients having bleeding from sites other than uterus. 4. Patient having coagulation disorders. 5. Patients using IUCDs. 6. Patient having diabetes, thyroid dysfunction.

Design outcomes

Primary

MeasureTime frame
reduction in bleeding through number of used pads per day during menstruationTimepoint: 3 months

Secondary

MeasureTime frame
pharmacognostical and phytochemical study of drugTimepoint: 2 months

Countries

India

Contacts

Public ContactNikita panwar

PGIA, DSRRAU, Jodhpur

chandan_singh4@yahoo.com9784617992

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026